Enanta Pharmaceuticals (NasdaqGS:ENTA) Update / Briefing September 29, 2025 08:30 AM ET Company ParticipantsJennifer Viera - VP - IR & Corporate CommunicationsJay Luly - President, CEO & DirectorScott Rottinghaus - Chief Medical OfficerJonathan Miller - MD - Biotech & Pharma Equity ResearchMazahir Alimohamed - Biotech Equity ResearchConference Call ParticipantsBrandon Folkes - MD & Senior Healthcare AnalystEd Arce - Senior Research Analyst - BiotechnologyBrian Skorney - Senior Research AnalystRoy Buchanan - ...